Home / Publications / Santen ends Neurim-style SPCs

Santen ends Neurim-style SPCs

14 July 2020

The wording of Article 3(d) of the SPC Regulation requires that the SPC application must rely on “the first authorisation to place the product on the market as a medicinal product”. This suggests that a marketing authorisation granted for a new indication of...

Read more

Authors

Robert Stephen
Robert Stephen
Partner
London